A PCT application can enter the United States national stage under 35 U.S.C. 371. The core deadline is generally 30 months from the priority date, and U.S.-specific requirements then govern fees, translations, examination and prosecution.
| Patent office | United States Patent and Trademark Office (USPTO) |
|---|---|
| Entry deadline | 30 months from the priority date for the core U.S. national-stage requirements. |
| Language / translation | English; an English translation is required if the international application was filed in another language. |
| Representation | The USPTO permits applicants to pursue patent applications themselves, but qualified U.S. patent counsel is commonly used for national-stage filing and prosecution, especially for complex claim strategy. |
| Portfolio question | The U.S. is often commercially significant for technology, life sciences, software, electronics, medical devices and other globally traded innovations. The filing decision should still be tied to U.S. market, licensing, manufacturing or enforcement value. |
This page separates current national-phase procedure from strategic filing considerations. Deadlines, fees and office rules can change, so consequential filing decisions should be verified against the official sources listed below.
Entering the U.S. national stage moves the international application into USPTO processing under U.S. patent law. The PCT filing itself does not create a U.S. patent. The national-stage application is examined by the USPTO and must satisfy U.S. requirements on patentability, disclosure, claim form and prosecution.
USPTO guidance states that the principal national-stage requirements are due no later than 30 months from the priority date. In particular, the Office requires the copy of the international application where necessary and the basic national fee by that deadline to avoid abandonment. Applicants should work to an earlier internal deadline because translations, inventor declarations, application data and prosecution instructions can require coordination.
Where the PCT application was not filed in English, an English translation is required for U.S. national-stage processing. The translation should be prepared carefully because technical wording can affect support, claim interpretation and later amendment strategy. Translation should therefore be treated as part of patent drafting quality, not merely an administrative formality.
The U.S. national stage can involve the basic national fee, search fee, examination fee, application-size fees and other charges depending on the application. USPTO procedures distinguish some items that must be completed by the 30-month deadline from other missing requirements that may be addressed after notification with applicable surcharges. Applicants should verify the current USPTO fee schedule rather than relying on static figures.
U.S. law permits early national-stage processing when the applicant expressly requests it and satisfies the relevant requirements. This can be useful where early examination is commercially valuable—for example before a financing, licensing program or product launch. Early processing should be coordinated with any Patent Prosecution Highway or accelerated-examination strategy.
The international search and written opinion can be useful, but they do not bind the USPTO. U.S. examiners apply U.S. law and examination standards. Software, AI, diagnostics, biotech and business-method-related inventions may face U.S.-specific eligibility or claim-drafting issues even where the international-stage record is favorable.
Applicants should consider whether the U.S. national-stage route alone provides the desired flexibility or whether later continuation, divisional or related U.S. filings may be useful. The international specification should therefore support multiple claim categories and commercially important embodiments where possible.
The strongest case for U.S. entry exists where the U.S. is an important sales market, licensing market, investor market, manufacturing or R&D location, or where major competitors operate. The decision should be weighed against prosecution complexity, expected claim scope, enforcement value and long-term maintenance cost.
Before the working deadline, confirm the priority chain, international publication, English translation status, applicant and inventor data, U.S. ownership record, current fee schedule, claim strategy and whether early processing is required. A last-minute national-stage filing can preserve rights but leave less time for strategic claim review.
Before entering the national phase in United States, re-check the controlling deadline, translation requirements, required application documents, representation rules, official fees and any available restoration or extension mechanism against the current patent-office or WIPO materials linked on this page. A national-phase decision should also confirm that the application being entered is the correct international application and that the claims, description and drawings support the commercial product. Procedural accuracy and portfolio value are separate questions, so both should be reviewed before fees are committed.
Entry into United States should be tied to a commercial reason. Relevant evidence can include expected revenue, manufacturing, technically significant infrastructure, competitors, licensees, investors, regulated-market access and the location of acts that could support infringement evidence. A large market is not automatically a high-value patent market for every invention. The strongest decision record states what commercial leverage the right is expected to create and what portfolio cost will be required through prosecution and maintenance.
The PCT application may contain broad claims, but the commercially useful position in United States can depend on who performs the claimed steps and how the product is deployed. Server-side, device, system, composition, method or manufacturing claims can create different enforcement positions depending on the technology. Before examination begins, identify the product features that matter, the likely competitor implementation and the evidence that could later show use of the claimed invention.
The national-phase deadline is not only a procedural event. It is a natural point to review product-market fit, licensing discussions, competitor activity, financing, technical changes and prior-art developments. If the invention has changed materially since the priority filing, prosecution strategy should be adjusted within the support available in the original disclosure. Jurisdictions that no longer support a clear business objective can be removed, allowing budget to move toward stronger markets or newer inventions.
Before acting on this page, identify the exact decision it is meant to support, the official source that controls any procedural requirement, the technical or commercial evidence that justifies the chosen jurisdiction, and the next deadline or document required. A clear decision record should also state what would cause the strategy to change. This makes the research usable during later prosecution, national-phase selection, budgeting and portfolio review rather than leaving it as a static summary.
Before acting on this page, identify the exact decision it is meant to support, the official source that controls any procedural requirement, the technical or commercial evidence that justifies the chosen jurisdiction, and the next deadline or document required. A clear decision record should also state what would cause the strategy to change. This makes the research usable during later prosecution, national-phase selection, budgeting and portfolio review rather than leaving it as a static summary.
Use official filing rules together with market, manufacturing, competitor, licensing, enforcement and technology considerations before committing to long-term prosecution cost.
rd (at) patentbusinesslawyer (dot) com
This national-phase guide explains entering the jurisdiction. For the separate question of taking an invention originating here into foreign markets, Read the origin-country international filing guide.
